Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Atherectomy Devices Market, by Type
1.4.2 Asia Pacific Atherectomy Devices Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Asia Pacific Atherectomy Devices Market by Type
3.1 Asia Pacific Directional Atherectomy Market by Country
3.2 Asia Pacific Rotational Atherectomy Market by Country
3.3 Asia Pacific Orbital Atherectomy Market by Country
3.4 Asia Pacific Laser Atherectomy Market by Country
Chapter 4. Asia Pacific Atherectomy Devices Market by Country
4.1 China Atherectomy Devices Market
4.1.1 China Atherectomy Devices Market by Type
4.2 India Atherectomy Devices Market
4.2.1 India Atherectomy Devices Market by Type
4.3 Japan Atherectomy Devices Market
4.3.1 Japan Atherectomy Devices Market by Type
4.4 South Korea Atherectomy Devices Market
4.4.1 South Korea Atherectomy Devices Market by Type
4.5 Singapore Atherectomy Devices Market
4.5.1 Singapore Atherectomy Devices Market by Type
4.6 Malaysia Atherectomy Devices Market
4.6.1 Malaysia Atherectomy Devices Market by Type
4.7 Rest of Asia Pacific Atherectomy Devices Market
4.7.1 Rest of Asia Pacific Atherectomy Devices Market by Type
Chapter 5. Company Profiles
5.1 Cardiovascular Systems, Inc.
5.1.1 Company Overview
5.1.2 Financial Analysis
5.1.3 Regional Analysis
5.1.4 Research & Development Expense
5.1.5 Recent strategies and developments:
5.1.5.1 Collaborations, partnerships and agreements:
5.1.5.2 Acquisition and mergers:
5.2 Avinger, Inc.
5.2.1 Company Overview
5.2.2 Financial Analysis
5.2.3 Regional Analysis
5.2.4 Research & Development Expense
5.2.1 Recent strategies and developments:
5.2.1.1 Product launches:
5.2.1.2 Approval:
5.3 Straub Medical AG
5.3.1 Company Overview
5.4 Boston Scientific Corporation
5.4.1 Company Overview
5.4.2 Financial Analysis
5.4.3 Segmental and Regional Analysis
5.4.4 Research & Development Expense
5.4.5 Recent strategies and developments:
5.4.5.1 Acquisition and mergers:
5.5 Medtronic PLC (Covidien)
5.5.1 Company overview
5.5.2 Financial Analysis
5.5.3 Segmental and Regional Analysis
5.5.4 Research & Development Expenses
5.5.5 Recent strategies and developments:
5.5.5.1 Acquisition and mergers:
5.5.5.2 Approval:
5.6 Koninklijke Philips N.V.
5.6.1 Company Overview
5.6.2 Financial Analysis
5.6.3 Segmental and Regional Analysis
5.6.4 Research & Development Expenses
5.6.5 Recent strategies and developments:
5.6.5.1 Acquisition and mergers:
5.7 Cardinal Health, Inc. (Cordis)
5.7.1 Company Overview
5.7.2 Financial Analysis
5.7.3 Segmental and Regional Analysis
5.8 Terumo Corporation (Terumo IS)
5.8.1 Company Overview
5.8.2 Financial Analysis
5.8.3 Segmental Analysis
5.8.4 Recent strategies and developments:
5.8.4.1 Acquisition and mergers:
5.8.4.2 Expansions:
5.9 Abbott Laboratories
5.9.1 Company Overview
5.9.2 Financial Analysis
5.9.3 Segmental and Regional Analysis
5.9.4 Research & Development Expense
5.9.5 Recent strategies and developments:
5.9.5.1 Acquisition and mergers:
5.1 B. Braun Melsungen AG
5.10.1 Company Overview
5.10.2 Financial Analysis
5.10.3 Segmental and Regional Analysis
5.10.4 Research & Development Expense
Unique Offerings 